From the FDA Drug Label
The FDA drug label does not answer the question.
From the Research
The recommended oral treatment for cutaneous candidiasis under the breasts is fluconazole 150 mg taken as a single dose, which may be repeated weekly for 2-4 weeks in more persistent cases. This recommendation is based on the most recent and highest quality study available, which demonstrated the efficacy and safety of fluconazole in treating cutaneous candidiasis 1. The study found that oral fluconazole was as effective as topical clotrimazole in treating cutaneous candidiasis, with complete cure rates of 73%-100% 1. Some key points to consider when using fluconazole include:
- The importance of maintaining good hygiene and keeping the affected area clean and dry
- Changing clothes frequently and considering the use of absorbent powders to reduce moisture
- Informing the healthcare provider of any liver disease or medications that may interact with fluconazole, such as warfarin or statins
- The potential for fluconazole to cause mild side effects, such as gastrointestinal complaints
- The need to individualize treatment based on the severity of the disease, history of recurrent infections, and patient preference 2. It's also worth noting that other treatments, such as itraconazole, may be effective in treating cutaneous candidiasis, but fluconazole is currently the most well-studied and widely recommended option 3.